Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Medical data aggregation tool developer Owkin increased its series A round to $52m after an extension backed by existing investors GV, Eight Road Ventures and F-Prime Capital.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

China Life Insurance has led a $78m series C round for Vazyme Biotech following the regulatory approval of its Covid-19 detection kit.

India-based challenger university Atria University has launched a VC fund contest for aspiring students aged from 16 to 18.

Cancer therapy developer Hummingbird Bioscience increased its series B haul to $25m after adding SK Group to a consortium that already included a division of Kooksoondang Brewery.

Each week, the Global Corporate Venturing Deal Net rounds up the week's smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Grail has added $390m in series D funding to its coffers thanks to a consortium featuring Illumina, significantly shooting past its $250m target size.

GV has invested in Ventus Therapeutics, an immunotherapy developer co-founded by faculty from multiple academic institutions.